Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of 1.30 is 22% above its 5-year average of 1.07, near the high end of its 5-year range (-1.09–2.06).
35.80% below its 12-month average of 2.02.
Reported quarterly EPS; no daily interpolation.
EPS growth vs the same quarter one year earlier, last 21 quarters.
Reported annual fiscal-period values; no daily interpolation.
EARNINGS PER SHARE (EPS)
1.30
EARNINGS PER SHARE (EPS) AVG TTM
2.02
EARNINGS PER SHARE (EPS) AVG 3Y
1.68
EARNINGS PER SHARE (EPS) AVG 5Y
1.07
EARNINGS PER SHARE (EPS) AVG 10Y
0.49
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
-35.80%
CURRENT VS 3Y AVG
-22.50%
CURRENT VS 5Y AVG
+22.07%
CURRENT VS 10Y AVG
+166.29%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Market Cap
$32.39B
Earnings Per Share (EPS)
3.45
TTM Avg
4.46
3Y Avg
4.05
5Y Avg
4.25
Market Cap
$32.14B
Earnings Per Share (EPS)
5.65
TTM Avg
10.02
3Y Avg
12.26
5Y Avg
14.06
Market Cap
$31.85B
Earnings Per Share (EPS)
-10.44
TTM Avg
-3.64
3Y Avg
-0.05
5Y Avg
0.88
Market Cap
$31.58B
Earnings Per Share (EPS)
5.92
TTM Avg
0.10
3Y Avg
-3.15
5Y Avg
-4.54
Market Cap
$30.94B
Earnings Per Share (EPS)
4.01
TTM Avg
10.78
3Y Avg
11.05
5Y Avg
10.65
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Alcon Inc. (ALC) | $34.85B | 1.30 | 2.02 | 1.68 | 1.07 |
| ResMed Inc. (RMD)vs › | $34.61B | 10.40 | 10.00 | 8.26 | 6.94 |
| DexCom, Inc. (DXCM)vs › | $34.12B | 2.53 | 1.80 | 1.48 | 1.30 |
| GE HealthCare Technologies Inc. (GEHC)vs › | $32.39B | 3.45 | 4.46 | 4.05 | 4.25 |
| Zoetis Inc. (ZTS)vs › | $32.22B | 6.07 | 5.75 | 5.27 | 4.80 |
| Biogen Inc. (BIIB)vs › | $32.14B | 5.65 | 10.02 | 12.26 | 14.06 |
| Centene Corp. (CNC)vs › | $31.85B | -10.44 | -3.64 | -0.05 | 0.88 |
| Alnylam Pharmaceuticals, Inc. (ALNY)vs › | $31.58B | 5.92 | 0.10 | -3.15 | -4.54 |
| Waters Corporation (WAT)vs › | $30.94B | 4.01 | 10.78 | 11.05 | 10.65 |
| Medline Inc. (MDLN)vs › | $29.83B | 0.86 | 1.48 | 0.80 | 0.80 |
Trailing EPS (TTM)
$1.30
Forward EPS (Est.)
$3.52
P/E Ratio
55.6
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | 1.99 |
| 2024-12-31 | 2.06 |
| 2023-12-31 | 1.98 |
| 2022-12-31 | 0.68 |
| 2021-12-31 | 0.77 |
| 2020-12-31 | -1.09 |
| 2019-12-31 | -1.34 |
| 2018-12-31 | -0.46 |
| 2017-12-31 | 0.52 |
| 2016-12-31 | -0.35 |
| 2015-12-31 | 0.61 |
